Mk. Osterlund et al., Effects of chronic 17 beta-estradiol treatment on the serotonin 5-HT1A receptor mRNA and binding levels in the rat brain, SYNAPSE, 35(1), 2000, pp. 39-44
Acute 17 beta-estradiol treatment had been shown to downregulate the 5-HT1A
receptor mRNA expression in limbic areas of the female rat brain. The aim
of the present study was to determine the effects of chronic 17 beta-estrad
iol treatment on 5-HT1A receptor mRNA expression and 5-HT1A receptor bindin
g in ovariectomized female rats. Using in situ hybridization histochemistry
, no alterations were found on the 5-HT1A receptor mRNA levels after the es
tradiol treatment (2 weeks). Radioligand autoradiographic studies using the
selective 5-HT1A receptor antagonist [H-3]WAY-100635 revealed reduced rece
ptor binding in the amygdala, hippocampus, perirhinal cortex, and motor cor
tex after estradiol treatment, whereas no changes were observed in the piri
form or retrosplenial cortex. Thus, the previous findings together with the
present results indicate that estradiol-induced alterations in 5-HT1A rece
ptor mRNA expression appears within hours, but diminishes with chronic trea
tment when significant changes on the receptor-protein level are apparent.
The effects of estradiol treatment on the 5-HT1A receptor binding in the li
mbic areas suggest that estrogen can modulate functions such as learning, m
emory, cognition, emotional processing, and social behavior. Consequently,
estradiol modulation of 5-HT1A receptor circuits might be a possible pathwa
y for the estrogen influence in the expression of psychiatric and neurologi
cal disorders such as Alzheimer's disease, affective disorders, and schizop
hrenia. Synapse 35:39-44, 2000. (C) 2000 Wiley-Liss, Inc.